Gut health supplement shows promise for IBS sufferers
NCT ID NCT04598295
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a daily synbiotic supplement (DS-01) in 48 adults with irritable bowel syndrome (IBS) to see if it is safe and helps improve gut health. Participants took either the supplement or a placebo for 12 weeks. The main goal was to check for side effects and see how the supplement affects gut bacteria and digestion.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IRRITABLE BOWEL SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could simple exercises calm gut inflammation and boost quality of life in IBS?
- Gut bacteria during infection may flag IBS risk
- Wheat sensitivity linked to fatty liver? a new study investigates
- Could a daily probiotic capsule tame irritable bowel syndrome?
- Can a simple diet switch calm IBS? a trial puts two popular eating plans to the test.
- Could a Dual-Action supplement tame irritable bowel syndrome?